
Shanghai
688317.SSShanghai ZJ Bio-Tech Co., Ltd. Price (688317.SS)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
192,756,441
(0.3605)%Revenue and Profitability
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 84,271,693 | 101,035,766 | 126,679,647 | 156,641,536 | 192,709,557 | 224,350,623 | 258,872,522 | 2,052,141,874 | 2,018,829,748 | 2,326,255,117 | 274,333,302 |
Net Income | 29,573,211 | 34,985,468 | 32,524,448 | 48,737,703 | 51,534,429 | 62,318,542 | 51,521,833 | 932,009,443 | 758,524,934 | 760,273,479 | -136,857,073 |
FCF USD | 14,435,145 | 5,737,863 | -10,907,707 | 12,701,768 | 19,355,695 | 63,147,131 | 53,103,558 | 1,067,218,676 | 143,876,424 | 510,413,531 | -163,030,700 |
OCF USD | 28,158,607 | 27,566,700 | 12,775,600 | 44,526,000 | 48,002,058 | 80,631,599 | 76,660,805 | 1,141,796,462 | 641,937,293 | 584,971,135 | -81,884,688 |
Financial Health - DEBT
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
YTPD | 0.00 | 0.27 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | -0.03 |
D/E | 0.12 | 0.10 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
CA/CL | 3.50 | 1.52 | 7.17 | 10.91 | 10.07 | 9.59 | 7.09 | 4.11 | 8.69 | 7.46 | 13.38 |
TA/TL | 3.28 | 2.24 | 7.76 | 12.34 | 11.89 | 12.34 | 9.16 | 4.51 | 9.96 | 8.73 | 16.35 |
Total Debt | 14,609,933 | 11,310,194 | 3,606,089 | 0 | 0 | 0 | 0 | 0 | 0 | 8,632,801 | 7,454,074 |
Management Performance
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
ROIC | 19.09% | 23.19% | 8.88% | 8.51% | 10.77% | 11.62% | 8.85% | 62.51% | 19.83% | 18.12% | -3.40% |
ROE | 25.09% | 31.75% | 9.47% | 10.07% | 10.90% | 11.70% | 9.01% | 63.72% | 19.82% | 18.10% | -3.58% |
ROA | 0.00% | 17.52% | 8.25% | 9.25% | 9.98% | 10.75% | 8.03% | 49.59% | 17.83% | 16.03% | -3.36% |
NM % | 35.09% | 34.63% | 25.67% | 31.11% | 26.74% | 27.78% | 19.90% | 45.42% | 37.57% | 32.68% | -49.89% |
FCF / R% | 0.00% | 5.68% | -8.61% | 8.11% | 10.04% | 28.15% | 20.51% | 52.01% | 7.13% | 21.94% | -59.43% |
FCF / NI% | 48.80% | 16.40% | -33.55% | 26.07% | 37.57% | 101.33% | 103.07% | 114.51% | 18.97% | 67.14% | 119.12% |
Operating Margin (OM) | 0.00 | 0.30 | 0.46 | 0.37 | 0.22 | 0.44 | 0.30 | 0.44 | 0.67 | 0.80 | 5.43 |
Per Share
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
EPS | 0.48 | 0.28 | 0.24 | 0.33 | 0.35 | 0.43 | 0.26 | 4.79 | 3.90 | 3.93 | -0.71 |
SPS | 1.37 | 0.81 | 0.93 | 1.06 | 1.31 | 1.55 | 1.33 | 10.54 | 10.37 | 12.02 | 1.42 |
OCPS | 0.46 | 0.22 | 0.09 | 0.30 | 0.33 | 0.56 | 0.39 | 5.86 | 3.30 | 3.02 | -0.42 |
FCPS | 0.23 | 0.05 | -0.08 | 0.09 | 0.13 | 0.44 | 0.27 | 5.48 | 0.74 | 2.64 | -0.85 |
BVPS | 1.92 | 0.88 | 2.53 | 3.28 | 3.21 | 3.68 | 2.94 | 7.51 | 19.66 | 21.71 | 19.84 |
Per Share - CAGR
Year | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
CAGR-EPS | 0.48 | 0.28 | 0.24 | 0.33 | 0.35 | 0.43 | 0.26 | 4.79 | 3.90 | 3.93 | -0.71 |
CAGR-SPS | 1.37 | 0.81 | 0.93 | 1.06 | 1.31 | 1.55 | 1.33 | 10.54 | 10.37 | 12.02 | 1.42 |
CAGR-OCPS | 0.46 | 0.22 | 0.09 | 0.30 | 0.33 | 0.56 | 0.39 | 5.86 | 3.30 | 3.02 | -0.42 |
CAGR-FCPS | 0.23 | 0.05 | -0.08 | 0.09 | 0.13 | 0.44 | 0.27 | 5.48 | 0.74 | 2.64 | -0.85 |
CAGR-BVPS | 1.92 | 0.88 | 2.53 | 3.28 | 3.21 | 3.68 | 2.94 | 7.51 | 19.66 | 21.71 | 19.84 |